Note any changes in your body weight, energy, or mood
This is particularly relevant as the BBB represents a major challenge in CNS drug delivery, often preventing neurotherapeutic agents from effectively reaching the brain
However, there have been few studies on the potential mechanism of the action of GLP-1RAs in the treatment of PCOS
Some protocols split the daily dose into morning and evening injections
A total of 131 medicines feature in the medicines landscape for PCOS, including 45 marketed products and 86 candidates in development
This common concern affects many patients starting glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy), liraglutide (Victoza, Saxenda), or dulaglutide (Trulicity) for type 2 diabetes or weight management